Abstract:Background Progressive deposition of cholesterol in the arterial wall characterizes atherosclerosis, which underpins most cases of myocardial infarction and stroke. Insulin-like growth factor-1 (IGF-1) is a hormone that regulates systemic growth and metabolism and possesses anti-atherosclerotic properties. However, the role of IGF-1 in the endothelium remains unexplored. Purpose To study the effect of increased endothelial IGF-1 receptor (IGF-1R) expression on atherogenesis using in vivo and in vitro models. Methods We generated atherosclerosis prone ApoE-/- transgenic mice with endothelium restricted overexpression of human IGF-1R (hIGFREO-ApoE-/-) or signalling defective K1003R mutant IGF-1R (mIGFREO-ApoE-/-). ApoE-/- littermates were controls. Following 12 weeks of western diet, we assessed atherosclerosis, systemic metabolism, leukocyte homeostasis and vascular permeability using histology, flow cytometry, metabolic testing, bone marrow transplantation and in vivo perfusion with either VE-Cadherin, Evans blue or BODIPY-LDL. For in vitro studies, human umbilical vein endothelial cells were transduced with custom-made lentivirus particles allowing doxycyline-inducible wild-type or mutant K1003R IGF-1R overexpression; with transduced cells not exposed to doxycycline as controls. Confluent cells were exposed to 100mM hydrogen peroxide to model the permeability-inducing conditions observed in atherosclerosis. In vitro, we assessed junctional proteins, FITC-dextran permeability and transcellular BODIPY-LDL uptake. Results We show that mice with endothelial overexpression of IGF-1R have less atherosclerosis, arterial cholesterol uptake, and vascular leakage of multiple organs. Conversely, mice with endothelial overexpression of signalling defective IGF-1R did not exhibit these phenomena. We found no differences in systemic metabolism or growth. In complementary in vitro studies, overexpressing wildtype IGF-1R altered the localization of some tight junction proteins (VE-Cadherin and Claudin 5) and reduced leakage across human endothelial monolayers; this was not observed with signalling defective IGF-1R. Moreover, it reduced endothelial cell internalization of cholesterol-rich lipoproteins and increased the association of these particles with clathrin, but not caveolin-1, both of which participate in vesicular uptake of lipoproteins. Conclusion Overall, our findings indicate that endothelial IGF-1 signalling modulates both para- and trans-cellular vascular barrier function. This is particularly relevant to the phenomenon of atherosclerosis and suggests that increased vascular IGF-1 signalling reduces atherosclerosis. Beyond this, our data are potentially relevant to many disease processes associated with altered vascular barrier function. This discovery could lead to novel therapeutics to normalise vascular barrier function.

[Protective Effect of Insulin-Like Growth Factor-1 on Vascular Endothelial Function in Hypercholesterolemia and the Underlying Mechanism].

The effect of measuring insulin- like growth factor I and nitric oxide on prognosis in patients with coronary heart disease

IGF-1 Alleviates Ox-Ldl-induced Inflammation Via Reducing HMGB1 Release in HAECs.

[Effects of Insulin Like Growth Factor-1 on Cell Viability and Tissue Factor in Vascular Endothelial Cells].

Insulin-like Growth Factor-1 Receptor Activation Prevents Hydrogen Peroxide-Induced Oxidative Stress, Mitochondrial Dysfunction and Apoptosis

Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesis

Studies on the Relations Between Angiotensin Ⅱ and Nitric Oxide and Insulin Like Growth Factot-1 and the Effects of Tongxinluo

The effects of IGF-1 and IGFBP-2 treatments on the atherosclerosis in the aorta and the coronary arteries of the high cholesterol diet-fed rabbits

The Protective Effects of Pioglitazone on Endothelial Function in Rats with Hypercholesterolemia

Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosis.

Insulin-Like Growth Factor 1 Alleviates High-Fat Diet-Induced Myocardial Contractile Dysfunction: Role of Insulin Signaling and Mitochondrial Function.

Role of Insulin-Like Growth Factor-1 (IGF-1) in Regulating Cell Cycle Progression

[Effects of Insulin-Like Growth Factor-1 on the Myocardium in Diabetic Rats].

GLP-1 Inhibits High-Glucose-Induced Oxidative Injury of Vascular Endothelial Cells

Relationship Between Insulin and Endothelial Function

Protective Effect of Oridonin Against the Injuries in Endothelial Cells

Abstract 12391: High Density Lipoprotein in Coronary Artery Disease Impairs Vascular Endothelial Growth Factor- Induced Angiogenesis

IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient Mice

Relationship of growth hormone/insulin-like growth factor-1 axis activity with plasma glucose and plasma lipid in elderly people

Epigallocatechin Gallate Preventing Low Density Lipoprotein-Induced Endothelial Dysfunction

Protective Effect of HDL on Endothelial NO Production: the Role of DDAH/ADMA Pathway